Melanoma, Secondary cancers, Skin cancer
Results
Phase 3
This trial compared binimetinib with dacarbazine for melanoma that can’t be removed with surgery, or has spread to another part of the body. It was for people who have melanoma with a change in a gene called NRAS.
Recruitment start: 19 August 2013
Recruitment end: 28 April 2015
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr James Larkin
Array Biopharma
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Novartis
Last reviewed: 23 Apr 2018
CRUK internal database number: 10622
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
